For its third fiscal quarter (ending September 30), Fidelity National Financial Inc (NYSE: FNF) has reported a 19% increase in E.P.S. from $1.33 a year ago to $1.58 in the current quarter. Relative to the […]
KKR & Co Inc (NYSE: KKR) has reported earnings for its third fiscal quarter (ending September 30) of $1.71 versus $0.04 for the same period a year ago — an increase of 4175%. This result […]
On 11/7/23, Ameresco Inc (NYSE: AMRC) stock suffered a major decline of -14.9%, closing at $22.65. The stock has been weak relative to the market over the last nine months and has declined -18.0% during […]
Alpha and Omega Semiconductor Li (NASDAQ: AOSL) stock suffered a major decline of -15.4% on 11/7/23. The shares closed at $21.53. The stock has declined -8.3% during the last week but has been exceptionally strong […]
Gen Digital Inc (NASDAQ: GEN) has reported E.P.S. of $0.23 for its second fiscal quarter (ending September 30) versus $0.12 for the same period a year ago — an increase of 92%. For the latest […]
Axon Enterprise Inc (NASDAQ: AXON) has reported earnings for its third fiscal quarter (ending September 30) of $0.79 versus $0.17 for the same period a year ago — an increase of 365%. This performance was […]
Surgery Partners Inc (NASDAQ: SGRY) has reported E.P.S. of $-0.04 for its third fiscal quarter (ending September 30) versus $-0.28 for the same period a year ago. This result fell short of the consensus estimate […]
Recent exceptional positive changes in investment behavior have benefitted OptimizeRX Corp (NASDAQ: OPRX): its shorter term price trend turned up, and positive upside/downside volume developed. OptimizeRX Corp (NASDAQ: OPRX) has benefited from significant positive changes […]
On 11/7/23, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) stock enjoyed a major increase of 12.2%, closing at $85.49. Relative to the market the stock has been weak over the last nine months but has risen 5.6% […]
MFA Financial Inc (NYSE: MFA) has reported E.P.S. of $-0.64 for its third fiscal quarter (ending September 30) versus $-0.62 for the same period a year ago. This performance was $-1.02 short of the consensus […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research